The β-amino acid BAY 10-8888/PLD-118 is currently being investigated in phase II clinical studies as a novel antifungal for the treatment of yeast infections. An efficient asymmetric synthesis of this compound is described. The key step employed a highly enantioselective, quinine-mediated alcoholysis of a meso-anhydride intermediate.
No takes yet. Share an insight, caveat, or question.
Mittendorf et al. (2003) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: